Artificial intelligence Health, Wellness & Biotech Robotics Startups Venture

The Week’s 10 Biggest Funding Rounds: xAI Leads As 2026 Is Off To A Brisk Start

Illustration of gardener holding a rake. Venture

Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board.

This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out last year’s biggest funding deal roundup here.

After a big year for venture investment, fueled by the AI boom, 2026 is not showing signs of a slowdown. Quite the contrary, with the first full week of the year bringing us a whopping $20 billion new funding round for Elon Musk’s xAI. We also counted multiple rounds of over $100 million that look minuscule by comparison but are actually very large by traditional venture standards.

1. xAI, $20B, generative AI: Musk’s xAI, the generative AI startup known for its Grok chatbot and the parent company of X (formerly Twitter), said it secured $20 billion in Series E funding from a long list of venture and strategic investors. Founded in 2023, xAI has raised $42.7 billion in reported debt and equity funding to date, per Crunchbase data.

2. Parabilis Medicines, $305M, precision medicines: Cambridge, Massachusetts-based Parabilis Medicines announced it raised $305 million in a Series F financing co-led by RA Capital Management, Fidelity and Janus Henderson Investors. The financing will support continued clinical development of its peptide platform for cancer therapeutics.

3. Soley Therapeutics, $200M, biotech: Soley Therapeutics, developer of a cell stress sensing platform and a pipeline of therapeutics for neurodegenerative disorders and metabolic diseases, closed on $200 million in Series C funding. Surveyor Capital led the financing for the South San Francisco, California-based company.

4. LMArena, $150M, AI: San Francisco-based LMArena, a platform for evaluating AI models and systems, picked up $150 million in fresh funding. Felicis Ventures 1 and UC Investments led the financing, which set a $1.7 billion post-money valuation, nearly triple the value at its seed round in mid-2025.

5. Diagonal Therapeutics, $125M, biotech: Diagonal Therapeutics, a biotech developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, raised $125 million in Series B funding. Sanofi Ventures and Janus Henderson Investors led the financing for the Watertown, Massachusetts-based company. 

6 (tied). Lyte, $107M, physical world AI: Mountain View, California-based Lyte, a startup focused on integrated perception for robotics and AI, emerged from stealth this week and disclosed it has raised $107 million in aggregate funding. The company says its mission is to “give robots the ability to see, understand, and operate safely in the physical world.”

6 (tied). EpiBiologics, $107M, biotech: EpiBiologics, a company working on tissue-selective extracellular protein degradation, says it completed a $107 million Series B financing. Google Ventures and Johnson & Johnson Innovation co-led the round for the San Mateo, California-based company.

8 (tied). Cambium, $100M, advanced materials: El Segundo, California-based Cambium, a startup developing advanced materials for defense, aerospace, and other sectors, secured $100 million in a Series B round led by 8VC 2

8 (tied). Rakuten Medical, $100M, cancer therapeutics: Rakuten Medical, a San Diego-based startup focused on photoimmunotherapy for cancer treatment, raised $100 million in Series F financing led by TaiAx. The company is currently enrolling patients into its global Phase 3 trial for recurrent head and neck cancer.

10. Pomelo Care, $92M, virtual care: Pomelo Care, a virtual healthcare provider for women and children, raised $92 million in a Series C funding led by Stripes. The financing set a $1.7 billion valuation for the New York-based company. 

Methodology

We tracked the largest announced rounds in the Crunchbase database that were raised by U.S.-based companies for the period of Jan. 3-9. Although most announced rounds are represented in the database, there could be a small time lag as some rounds are reported late in the week.

Illustration: Dom Guzman


  1. Felicis Ventures is an investor in Crunchbase. They have no say in our editorial process. For more, head here.

  2. 8VC is an investor in Crunchbase. They have no say in our editorial process. For more, head here.

Tags

Stay up to date with recent funding rounds, acquisitions, and more with the Crunchbase Daily.

Copy link